Skip to main content
Home
Medic Debate
- The Antidote to Medical Misinformation and Propaganda!

Languages

Search form

Main menu

  • Home
  • Search
  • Category Search
  • Log In
  • Peoples Court
  • Recent posts
  • Treatment Protocols

You are here

Home

Sorafenib

Title Average Ratingsort ascending
A phase II study of sorafenib in combination with tegafur/uracil (UFT) for Asian patients with advanced hepatocellular carcinoma 80.00%
Phase II trial of pharmacodynamically (PDally)-guided optimal biologic dose titration (OBDT) of sorafenib (S) in combination wit 70.00%
Sorafenib and radiation: A promising combination in colorectal and pancreas cancer 70.00%
Metastatic chest wall malignant schwannoma responding to sorafenib: case report and literature review. 70.00%
Clinical management of adrenocortical carcinoma 60.00%
A phase II clinical trial of sorafenib in androgen-independent prostate cancer. 60.00%
Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase path-- 60.00%
Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer. 50.00%
Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors. 50.00%
Tumoral angiogenesis: review of the literature. 50.00%
Bioavailability of sorafenib tablets administered as a liquid suspension. 30.00%